Medicare Scores Major Win With Lower Prices for These 10 High-Cost Drugs

by DTM | Posted on

These are 3 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Entresto, Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp.

For almost two decades, Medicare was banned from negotiating drug prices. The Inflation Reduction Act changed that.